4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228341
Chief Financial Officer sold 10,558 shares at $14.65 ($154,650)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2025-09-30 | Sale | −10,558 | $14.65 | $154,650 | 280,430 | D |
| Open-market sales · 10,558 sh · avg $14.65 · $154,650 | |||||||
Loading xslF345X05/ownership.xml…